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Abstract In a search for new inhibitors of the IFN-Q mediated
signal transduction in HeLa S3 cells using secreted alkaline
phosphatase (SEAP) as reporter gene, the novel pyran-dione
trichodion was isolated from fermentations of the imperfect
fungus Trichosporiella sp. 20-95. The compound inhibits the
IFN-Q mediated expression of the reporter gene with IC50 values
of 21^42 WM (5^10 Wg/ml). The NF-UB and AP-1 mediated
expression of the reporter gene are inhibited with IC50 values of
42^84 WM (10^20 Wg/ml) and 21 WM (5 Wg/ml) respectively.
Western blotting with COX-2 and NOS II antibodies showed
that the expression of both proinflammatory enzymes is almost
completely inhibited at 21^42 WM (5^10 Wg/ml) in LPS/IFN-Q
stimulated J774 mouse macrophages. Studies on the mode of
action of the compound revealed that the inhibition of the NF-UB
dependent pathway is due to the stabilization of the IUB protein
and the inhibition of the IFN-Q dependent signaling is caused by
an inhibition of the phosphorylation of the STAT1K transcription
factor. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Altered gene expression is fundamental to the ethiology of
many human diseases including cancer, in£ammation and im-
mune disorders. Many genes for proin£ammatory enzymes
(e.g. COX-2, NOS II) and cytokines (e.g. TNF-K) contain
binding sites for multiple transcription factors in their regu-
latory elements, which are activated by a variety of inducing
agents like bacterial lipopolysaccharide (LPS), tumor pro-
moters, cytokines (e.g. IFN-Q) and growth factors. Inhibitors
which speci¢cally interfere with components of di¡erent intra-
cellular signaling pathways or inhibit the activation of tran-
scription factors responsible for the expression of disease re-
lated genes may have applications as novel therapeutics in
in£ammation [1,2]. Besides the transcription factor NF-UB
which is an immediate early transcriptional activator [3,4],
components of the JAK/STAT pathway play an important
role in the transcriptional activation of many in£ammatory
genes. Exposure of cells to interferon-Q triggers the phosphor-
ylation of latent cytoplasmatic transcription factors termed
STATs [5]. The STATs become phosphorylated on tyrosine
residues by one or more members of the JAK family of pro-
tein tyrosine kinases then assemble in dimeric or oligomeric
form, enter the nucleus and regulate transcription of many
genes by binding to speci¢c DNA sequences (STAT binding
elements, SBE) [6]. IFN-Q has been shown to induce tyrosine
phosphorylation of STAT1K and a homodimeric complex of
STAT1K binds to the IFN-Q activation sequence (GAS).
STAT1 and STAT2 are tyrosine phosphorylated in response
to IFN-K/L and form a complex with the DNA binding pro-
tein p48, which moves to the nucleus and activates the tran-
scription of genes bearing the interferon responsive element
(ISRE) [7]. SBE and NF-UB binding sites have been found in
the promoters of in£ammatory genes including those encoding
for NOS II and ICAM and a functional synergy of IFN-Q and
TNF-K has been reported [8]. In order to search for fungal
metabolites inhibiting the IFN-Q dependent signaling path-
way, reporter gene vectors were constructed which express
the reporter gene under the control of ¢ve copies of the
GAS/ISRE responsive element. A screening of 500 mycelial
cultures of basidiomycetes, ascomycetes and imperfect fungi
resulted in the isolation of trichodion from the deuteromycete
Trichosporiella sp. In this paper the biological properties of
trichodion are described.
2. Materials and methods
2.1. Producing organism
The deuteromycete strain 20-95 was isolated from a soil sample
collected in Germany. The specimen showed the characteristics of
the genus Trichosporiella as described by Domsch et al. [9]. The spe-
cies however could not be identi¢ed. The strain was kindly provided
by H. Anke and is deposited in the culture collection of the LB
Biotechnologie, Universita«t Kaiserslautern.
2.2. Fermentation
For maintenance on agar slants the strain was kept on YMG me-
dium [10]. For submerged cultivation, strain 20-95 was grown in malt
extract medium (40 g/l malt extract). A well grown seed culture of
Trichosporiella sp. 20-95 (200 ml YMG medium) was used to inocu-
late a Biola¢tte C-6 fermenter containing 20 l of malt extract medium
with aeration (3 l air/min) and agitation (120 rpm) at 22‡C. The
production of trichodion was followed by the inhibitory e¡ect of
various concentrations of a crude extract of the culture £uid in the
reporter gene assay as described below.
2.3. Isolation of trichodion
After 9 days the culture £uid was separated by ¢ltration and ap-
plied onto Mitsubishi DIAION HP 21 resin. The resin was washed
with water and the active compound was eluted with acetone. The
eluate was concentrated and the remaining aqueous residue extracted
with EtOAc. The solvent was evaporated and the crude product (1.16
g) was separated by chromatography on silica gel (Merck 60) with
cyclohexane:EtOAc (50:50) as eluent resulting in 155 mg of an en-
riched product. Precipitation from acetonitrile yielded 62 mg of pure
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trichodion. The structural elucidation was done by spectroscopic
methods and will be published elsewhere.
2.4. Biological assays
COS-7 (ATCC CRL 1651) and HeLa S3 (ATCC CCL 2.2) cells
were maintained in DMEM medium supplemented with 10% fetal
calf serum (FCS) and 65 Wg/ml penicillin G and 100 Wg/ml strepto-
mycin sulfate. J774 (DSMZ ACC 170) and Jurkat (ATCC TIB 152)
cells were grown in RPMI 1640 medium with 10% FCS. The assays
for antimicrobial activity, cytotoxicity as well as macromolecular syn-
theses in HeLa S3 cells were carried out as described previously [11].
2.5. Reporter gene assays
The reporter plasmids pGE3-NF1 and pGE2-AP1 have been de-
scribed recently [12]. Both plasmids carry the reporter gene secreted
alkaline phosphatase (SEAP) under the control of a thymidine kinase
promoter and 5UNF-UB or an enhancerless SV40 promoter and
3UAP-1 binding sites. The reporter plasmid pGE3-GAS/ISRE was
constructed essentially as described earlier by cloning ¢ve copies of
an GAS/ISRE consensus oligonucleotide (5P-AAGTACTTT-
CAGTTTCATATTACTCTA-3P) immediately upstream of the thymi-
dine kinase promoter driven SEAP reporter gene [12]. The reporter
plasmid pGE3-NFAT contains the reporter gene SEAP under the
control of the thymidine kinase promoter and ¢ve copies of the distal
NF-AT/AP-1 binding site from the human IL-2 promoter [13]. The
reporter plasmid pGE2-GRE contains the reporter gene SEAP under
the control of the enhancerless SV40 promoter and three copies of the
glucocorticoid responsive element (GRE) [14]. In addition, the activa-
tion of the glucocorticoid receptor mediated expression of the reporter
gene in COS-7 cells has been determined by cotransfection of the
human glucocorticoid receptor-K (pRShGR, ATCC 67200). Transfec-
tion of HeLa S3 and COS-7 cells and determination of the activity of
the expressed SEAP were performed as described previously [15]. The
transfection of Jurkat cells was performed by electroporating (Bio-
Rad, Gene Pulser) 6U107 cells/ml in 0.2 ml HEBS bu¡er (10 mM
HEPES, pH 7.05, 68.5 mM NaCl, 2.5 mM KCl, 0.35 mM Na2HPO4,
3 mM dextrose) together with 30 Wg of the pGE3-NFAT plasmid at
500 V/cm. After electroporation the cells were seeded at 1U106
cells/ml OPTI-MEM containing 10% FCS in a 24 well plate with
and without test compounds and SEAP expression was induced
with 32 nM TPA and 2 WM ionomycin. The activity of the SEAP
in the culture medium was determined 24 h after transfection using
the Phospha-Light chemoluminescent reporter gene assay (Tropix,
MA) according to the manufacturer’s instructions with a liquid scin-
tillation counter.
2.6. Western blots
J774 cells were starved for 16 h in DMEM medium with 0.5% FCS,
treated for the indicated times with test compounds and induced with
1 Wg/ml LPS and 10 ng/ml IFN-Q in DMEM medium containing 0.5%
FCS. Total cell extracts were prepared using a high salt detergent
bu¡er (20 mM HEPES, pH 7.4, 350 mM NaCl, 20% glycerin, 1%
NP-40, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 0.5 mM
DTT, 10 mM NaF, 1 mM Na3VO4), complete protease inhibitor
cocktail 1:50 (Roche Diagnostics, Germany) and cell extracts (50^
100 Wg protein) were subjected to 10% SDS^PAGE, transferred
onto a nitrocellulose membrane, probed with either an anti-IUB anti-
body, anti-COX-2 antibody, anti-NOS II antibody (Santa Cruz Bio-
technology, Santa Cruz, CA, USA), an anti-phosphotyrosine-STAT1K
antibody or an antiphospho-p38 antibody (NEB Inc.) and then with
the appropriate secondary antibody conjugated to horseradish peroxi-
dase. Immunoreactive proteins were visualized by the enhanced che-
moluminescent detection system (ECL system, Amersham Interna-
tional, UK).
IL-2 production in Jurkat cells pretreated for 1 h with or without
test compounds and stimulated with 32 nM TPA and 2 WM ionomy-
cin for additional 24 h, was determined by ELISA (Quantikine human
IL-2, R and D Systems, UK) according to the manufacturer’s instruc-
tions.
3. Results
Trichodion (Fig. 1) has been detected during fermentation
and isolation using SEAP reporter plasmids containing multi-
ple GAS/ISRE sites in their promoter (pGE3-GAS/ISRE).
Transfection of HeLa S3 cells and stimulation with 10 ng/ml
IFN-Q resulted in a 8^10-fold increase in SEAP expression
compared to the uninduced control. Trichodion inhibited
the IFN-Q induced SEAP expression with IC50 values of 21^
42 WM (5^10 Wg/ml; Fig. 2). The TNF-K induced expression
of the NF-UB dependent reporter plasmid (pGE3-NF1) in
transiently transfected HeLa S3 cells was inhibited with IC50
values of 42^84 WM (10^20 Wg/ml). In addition trichodion
suppressed the AP-1 mediated gene activation in transiently
transfected, TPA stimulated COS-7 cells with an IC50 value of
21 WM (5 Wg/ml). In order to determine the e¡ect of tricho-
dion on the glucocorticoid receptor mediated gene expression,
COS-7 cells were transiently transfected with a GRE driven
reporter vector together with an expression vector for the
human glucocorticoid receptor-K. The inhibition of the gluco-
corticoid receptor dependent SEAP expression was about
5-fold lower than the inhibition of the IFN-Q or TPA induced
expression of the reporter gene (IC50 : 25 Wg/ml, 105 WM).
The inhibition of the reporter gene expression did not result
from a non-speci¢c interference with cellular DNA, RNA,
and protein syntheses or a decrease in cell viability since a
pronounced in£uence on the macromolecular syntheses in
HeLa S3 cells or cytotoxic e¡ects could only be observed at
concentrations higher than 50 Wg/ml of trichodion (Fig. 3).
It has been shown that the inducible expression of the
proin£ammatory enzymes COX-2 and iNOS in murine and
human cell lines by LPS, TNF-K, IL-1L, TPA or IFN-Q re-
quires consensus sequences for the transcription factors NF-
UB, AP-1 and STAT1K in their promoters, which are acti-
vated by di¡erent signal transduction pathways [16^19]. In
order to determine the e¡ect of trichodion on COX-2 andFig. 1. Structure of trichodion.
Fig. 2. E¡ect of trichodion on SEAP reporter gene expression in
HeLa S3 and COS-7 cells. HeLa S3 cells were transfected with a
GAS/ISRE (5UGAS/ISRE-SEAP) or an NF-UB (5UNF-UB-SEAP)
dependent reporter gene and stimulated with 10 ng/ml IFN-Q (GAS/
ISRE) or 5 ng/ml TNF-K (NF-UB) for 48 h with or without tricho-
dion. COS-7 cells were transfected with an AP-1 dependent reporter
gene (3UAP-1-SEAP) or a glucocorticoid responsive reporter gene
(3UGRE-SEAP) together with an expression vector for the human
glucocorticoid receptor-K and stimulated with 50 ng/ml TPA (AP-1)
or 1 WM dexamethasone (3UGRE) for 48 h with or without tricho-
dion. Control (100%): stimulation only.
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iNOS expression J774 cells were stimulated for 12 h with LPS
and IFN-Q with or without test compound and immunoblot-
ted for COX-2 and iNOS proteins. As shown in Fig. 4 treat-
ment of J774 cells with 1 Wg/ml LPS and 10 ng/ml IFN-Q
resulted in a strong induction of iNOS and COX-2 expression.
Cotreatment with trichodion caused a dose dependent de-
crease in LPS/IFN-Q mediated induction of both enzymes.
At 5 Wg/ml (21 WM) the expression of the iNOS and COX-2
protein is almost completely inhibited. To elucidate the mech-
anism responsible for the inhibition of COX-2 and iNOS ex-
pression we determined the in£uence of trichodion on the
LPS/IFN-Q mediated degradation of the inhibitory protein
IUB-K in J774 cells. As shown in Fig. 5A stimulation of
J774 cells with IFN-Q and LPS for 30 min resulted in the
disappearance of the IUB protein which was completely inhib-
ited by 10 Wg/ml (42 WM) of trichodion. These data ¢t well to
the ones obtained with the NF-UB dependent reporter gene
assay and suggest that trichodion inhibits the LPS/IFN-Q in-
duced activation of NF-UB in J774 macrophages.
To determine whether the inhibition of the IFN-Q depen-
dent reporter gene in HeLa S3 cells and the LPS/IFN-Q in-
duced expression of the proin£ammatory enzymes COX-2 and
iNOS in J774 cells is due to an inhibition of tyrosine phos-
phorylation of the STAT1K transcription factor, Western
blots have been performed with a phospho-STAT1 (Tyr701)
antibody. As shown in Fig. 5B treatment of J774 cells with
LPS/IFN-Q resulted in a strong induction of tyrosine phos-
phorylation of the STAT1K protein. Pretreatment of the cells
with trichodion inhibited the phosphorylation in a dose de-
pendent manner. Trichodion markedly reduced the phosphor-
ylation of the STAT1K protein at 5 Wg/ml (21 WM). At 10
Wg/ml the phosphorylation was reduced to the background
comparable to the uninduced control. It has been shown
that the expression of the inducible COX-2 and NOS II in
LPS stimulated macrophages depends on the activation of
di¡erent members of the mitogen activated protein kinases
(MAPKs) which directly or indirectly activate a number of
transcription factors including AP-1 and NF-UB [18,20,21].
Among the MAPKs, the JNK/SAPK and p38 MAPK path-
ways share activation by in£ammatory cytokines, bacterial
endotoxins and environmental stress. To determine whether
trichodion inhibits the activation of the p38 MAPK Western
blots were performed with a antibody speci¢c for the phos-
phorylated form of p38 (Thr180/Tyr182). The results are
shown in Fig. 5C. Treatment of J774 macrophages with
LPS and IFN-Q alone increased the p38 phosphorylation.
The level of p38 phosphorylation was markedly increased
by cotreatment of the cells with various concentrations of
trichodion. In addition treatment of J774 cells with trichodion
alone resulted in an increase of p38 phosphorylation at con-
centrations starting from 20 Wg/ml (data not shown).
The transcription factors AP-1, NF-UB and NF-AT have
been shown to be essential for the inducible interleukin-2 (IL-
2) expression in activated T cells [22]. Treatment of Jurkat
cells with ionomycin which elevates intracellular levels of cal-
cium and the phorbol ester TPA which activates protein ki-
nase C can mimic the activation of T cells by the T cell
receptor [23]. In order to determine the e¡ect of trichodion
on T cell activation Jurkat cells were transiently transfected
with a reporter plasmid expressing the reporter gene under the
control of ¢ve copies of the distal NF-AT/AP-1 binding site
from the human IL-2 promoter immediately cloned upstream
of the thymidine kinase promoter as described in Section 2.
Fig. 3. E¡ect of trichodion on the incorporation of radiolabelled
precursors into macromolecules of HeLa S3 cells. Control without
test compound (100%): [14C]thymidine, 7332 cpm, [14C]uridine,
42737 cpm, [14C]leucine, 39565 cpm.
Fig. 4. E¡ect of trichodion on NOS II and COX-2 expression in
J774 cells. J774 cells were pretreated for 1 h with or without tricho-
dion and stimulated with 1 Wg/ml LPS and 10 ng/ml IFN-Q for 12 h.
Subsequently total cell extracts were prepared and equal amounts of
protein (80 Wg) analyzed by Western blotting for A: NOS II expres-
sion with an NOS II antibody and B: COX-2 expression with a
COX-2 antibody.
Fig. 5. E¡ect of trichodion on IUB degradation, STAT1K and p38
phosphorylation in J774 cells. J774 cells were pretreated for 1 h
with or without trichodion and stimulated with 1 Wg/ml LPS and
10 ng/ml IFN-Q for 30 min. Subsequently total cell extracts were
prepared and equal amounts of protein (80 Wg) analyzed by West-
ern blotting for A: IUB degradation using a IUB-K antibody,
B: STAT1K phosphorylation with a phospho-STAT1K antibody
and C: p38 phosphorylation with a phospho-p38 antibody.
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Trichodion inhibited the TPA/ionomycin induced NF-AT
mediated SEAP expression with an IC50 of 5 Wg/ml (21
WM). At the same concentration the inducible IL-2 expression
was reduced to 10% of the untreated control (Fig. 6A,B).
Higher concentrations (s 10 Wg/ml) completely blocked the
IL-2 synthesis in Jurkat cells.
4. Discussion
The inducible isoforms of cyclooxygenase (COX-2) and ni-
tric oxide synthase (iNOS) are expressed by many cell types
including macrophages and endothelial cells upon stimulation
with proin£ammatory cytokines and bacterial cell wall com-
ponents. The expression of COX-2 and iNOS promotes the
synthesis and release of large amounts of bioactive lipids such
as prostaglandins, leukotrienes and nitric oxide which are me-
diators involved in the in£ammatory processes [24,25]. The
inhibition of the diverse signal transduction pathways leading
to the expression of COX-2 and iNOS may be of therapeutic
use for the treatment of chronic diseases such as rheumatoid
arthritis or for the acute situations such as septic shock [26].
We have isolated a novel compound from fermentation of
the deuteromycete Trichosporiella sp. that inhibits the LPS
and IFN-Q mediated inducible expression of the proin£amma-
tory enzymes COX-2 and iNOS in J774 macrophages. The
mechanisms by which trichodion inhibits COX-2 and iNOS
expression appear to involve the direct interference with sev-
eral signal transduction pathways responsible for the inducible
transcriptional activation of the corresponding promoters.
Trichodion blocked the TNF-K induced expression of an
NF-UB dependent reporter gene. In addition we have shown
that the compound inhibited the LPS/IFN-Q mediated degra-
dation of the IUB-K protein and subsequent activation of the
NF-UB transcription factor. Besides NF-UB, the activation of
the transcription factor AP-1 by di¡erent members of the
mitogen activated protein kinases (MAPKs) has been de-
scribed to function as important regulators of COX-2 and
iNOS expression in various cell lines [19,21,27,28]. It has
been shown that inhibition of the p38 MAPK by SB203580
and/or the MEK1,2/ERK pathway by PD98059 resulted in a
reduction of COX-2 and iNOS expression in LPS or LPS/
IFN-Q stimulated macrophages [20,29,30]. The compound tri-
chodion inhibited the expression of an AP-1 dependent re-
porter gene in COS-7 cells after stimulation with the phorbol
ester TPA (which activates the ERK1,2 pathway) and it seems
conceivable that trichodion interferes with one or several ki-
nases involved in that pathway or inhibits the activation of a
common kinase upstream of IUB. In addition trichodion acti-
vated the phosphorylation of p38 as determined by Western
blots with a phosphospeci¢c antibody. These results indicate
that the compound does not act as a global kinase inhibitor.
The inhibition of the AP-1 dependent signaling pathway
may also contribute to the observed immunosuppressive prop-
erties of trichodion since it has been shown that the activation
of the ERK cascade is required for IL-2 production and tran-
scriptional activation of the distal NF-AT/AP-1 SEAP report-
er gene in TPA/ionomycin or anti-CD3/anti-CD28 stimulated
Jurkat cells [31,32]. In addition we have shown by Western
blots with a phosphospeci¢c antibody that trichodion inhibits
the tyrosine phosphorylation of the STAT1K protein in LPS/
IFN-Q stimulated J774 cells and suppresses the GAS/ISRE
dependent expression of the SEAP reporter gene in IFN-Q
stimulated HeLa S3 cells.
Several natural compounds including cyclointeinone, a ter-
pene from the sponge Cacospongia linteiformis, the diterpene
andalusol, curcumin, various £avonoids, salicylate and the
polyphenol oroxylin have been described to inhibit the induc-
ible expression of either COX-2 or iNOS [33^38]. The antiin-
£ammatory properties of these chemically diverse compounds
have been mainly attributed to an inhibition of the activation
of the transcription factor NF-UB which participates in the
regulation of expression of immediate early genes involved in
immune, acute phase and in£ammatory responses. Further-
more an inhibition of COX-2 gene expression in human mam-
mary epithelial cells after stimulation with TPA has recently
been described for resveratrol, a phenolic antioxidant from
grapes [39]. The mechanism by which resveratrol modulates
gene expression involves the inhibition of PKC translocation
to the membrane and the blocking of the induction of the
COX-2 promoter mediated by ERK1 and c-jun. Thus resver-
atrol interferes with the PKC signaling leading to the activa-
tion of the transcription factor AP-1.
The novel pyran-dione trichodion is chemically not related
to the compounds mentioned above and our ¢ndings indicate
that the inhibition of COX-2 and iNOS expression in LPS/
IFN-Q stimulated macrophages by trichodion is the result of
Fig. 6. E¡ect of trichodion on NF-AT/AP-1 dependent SEAP reporter gene expression and IL-2 synthesis in Jurkat cells. A: Jurkat cells were
transfected with an NF-AT/AP-1 dependent reporter gene (5UNF-AT/AP-1) and stimulated with 32 nM TPA and 2 WM ionomycin for 24 h
with or without trichodion. Control (100%): stimulation only. B: Jurkat cells were pretreated for 1 h with or without trichodion and stimulated
with 32 nM TPA and 2 WM ionomycin for additional 24 h. IL-2 concentrations from cell supernatants were determined by ELISA.
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the interference with di¡erent signaling pathways. Trichodion
inhibits the NF-UB, AP-1 and STAT1 mediated gene expres-
sion but the exact cellular target remains to be determined.
Another interesting question is which structural properties of
trichodion account for the inhibition of COX-2 and iNOS
expression and therefore analogues of trichodion are needed
in order to determine the structure^activity relationship.
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